FAMILIAL OVARIAN-CANCER

被引:7
|
作者
VANEIJKEREN, MA
DEGRAAFF, J
VANETTEN, FHPM
机构
[1] ST ELIZABETH HOSP,DEPT OBSTET & GYNAECOL,TILBURG,NETHERLANDS
[2] ST ELIZABETH HOSP,DEPT PATHOL,TILBURG,NETHERLANDS
来源
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY | 1992年 / 47卷 / 03期
关键词
OVARIAN CANCER; PREVENTION; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1016/0028-2243(92)90164-T
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Familial ovarian cancer occurs in approximately 5% of all ovarian cancers. Since the relation between ovarian cancer and genetic heritage has drawn much attention lately, general gynaecologists will more and more be faced with the question how to survey patients from a family with the familial ovarian cancer syndrome. We describe a patient from a family with three daughters, of which two older sisters were known to have ovarian cancer. Although our patient was closely observed, a third-stage ovarian cancer developed. With this case in mind and after a review of the literature, we will in future closely survey patients from familial ovarian cancer families from their twentieth birthday on, and recommend prophylactic bilateral oophorectomy after child-bearing age. However, we are aware of the fact that it is impossible to diagnose ovarian cancer in a premalignant phase as yet, and the benefit of a close survey might be an earlier diagnosis and not prevention. Also, prophylactic oophorectomy does not prevent the occurrence of intra-abdominal malignancies histopathologically indistinguishable from ovarian cancer. Patients should be aware of these restrictions. If, in the future, the precise chromosomal defect in ovarian cancer families is localized, prevention of ovarian cancer, but not of intra-abdominal malignancies of the same histopathology, might be within reach.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 50 条
  • [21] FERTILITY DRUGS AND OVARIAN-CANCER
    COHEN, J
    FORMAN, R
    JOHANNISSON, E
    LUNENFELD, B
    DEMOUZON, J
    PEPPERELL, R
    TARLATZIS, B
    TEMPLETON, A
    FERTILITY AND STERILITY, 1993, 60 (03) : 406 - 408
  • [22] OVULATION SIDE AND OVARIAN-CANCER
    BALASCH, J
    PENARRUBIA, J
    MARQUEZ, M
    MIRKIN, SR
    CARMONA, F
    BARRI, PN
    VANRELL, JA
    GYNECOLOGICAL ENDOCRINOLOGY, 1994, 8 (01) : 51 - 54
  • [23] OVARIAN-CANCER - EPIDEMIOLOGIC AND CLINICAL PERSPECTIVES AND THE FEASIBILITY OF SCREENING
    BASS, KM
    WESTHOFF, C
    BUSH, TL
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 1995, 2 (03): : 145 - 158
  • [24] EPITHELIAL OVARIAN-CANCER - THE ROLE OF RADIOTHERAPY
    DEMBO, AJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05): : 835 - 845
  • [25] OVARIAN-CANCER SCREENINGS - CRITICAL ANALYSIS
    PENNEHOUAT, G
    GUGLIEMINA, JN
    NAOURI, M
    CREQUAT, J
    BOURET, JM
    THEBAULT, Y
    MADELENAT, P
    CONTRACEPTION FERTILITE SEXUALITE, 1993, 21 (03): : 223 - 230
  • [26] FLOW CYTOMETRIC EVALUATION OF OVARIAN-CANCER
    BRALY, PS
    KLEVECZ, RR
    CANCER, 1993, 71 (04) : 1621 - 1628
  • [27] INTRAPERITONEAL CHEMOTHERAPY IN THE MANAGEMENT OF OVARIAN-CANCER
    MARKMAN, M
    REICHMAN, B
    HAKES, T
    CURTIN, J
    JONES, W
    LEWIS, JL
    BARAKAT, R
    RUBIN, S
    MYCHALCZAK, B
    SAIGO, P
    ALMADRONES, L
    HOSKINS, W
    CANCER, 1993, 71 (04) : 1565 - 1570
  • [28] HEREDITARY OVARIAN-CANCER - A CLINICOPATHOLOGICAL STUDY
    BEWTRA, C
    WATSON, P
    CONWAY, T
    READHIPPEE, C
    LYNCH, HT
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1992, 11 (03) : 180 - 187
  • [29] PROLONGED INTAKE OF CHLORAMBUCIL FOR OVARIAN-CANCER
    KHALIL, AM
    KHATIB, RA
    SHAMSEDDINE, AI
    SHARARA, NH
    SEOUD, MAF
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 60 (01): : 85 - 86
  • [30] CYTOREDUCTIVE SURGERY IN EPITHELIAL OVARIAN-CANCER
    MICHEL, G
    CASTAIGNE, D
    PRADE, M
    PATHOLOGIE BIOLOGIE, 1991, 39 (09): : 826 - 827